FTOX043 Evaluation of the toxicity of pseudoboehmite for the controlled release of drugs
Abstract
The nanotechnology research progressed significantly over the past 30 years, allowing for the development of new materials with applications that meet the interests of various sectors. In health, the pharmaceutical industry has used nanostructured materials to develop the release of drugs. Application of the nanoparticles offers numerous advantages compared to conventional release, such as progressive and controlled release of drugs from the matrix degradation, effective plasma levels with less fluctuation over time, less risk of toxicity, biological penetration through the barriers and targeting to specific tissue targets. In this study, the material used in drug delivery is pseudoboehmite. The pseudoboehmite consists in an advanced synthetic ceramic with enhanced characteristics of composition, morphology and desired particle size. It is based on an oxyhydroxide aluminum and its structure is similar to boehmite.Downloads
Download data is not yet available.
Downloads
Published
2012-12-27
How to Cite
DE SOUZA, A. M. T.; MARTINS, M. V. S.; RIBEIRO, R. R.; CYSNEIROS, R. M.; NOVICKIS, R. W.; SIRVENTE, R. de A.; MUNHOZ JR, A. H. FTOX043 Evaluation of the toxicity of pseudoboehmite for the controlled release of drugs. Revista Eletrônica de Farmácia, Goiânia, v. 9, n. 1, p. 1, 2012. Disponível em: https://revistas.ufg.br/REF/article/view/21890. Acesso em: 22 dec. 2024.
Issue
Section
Artigos Originais
License
Copyright (c) 2021 Revista Eletrônica de Farmácia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Termo de responsabilidade de autoria e acordo de transferência do copyright, indicando a categoria do artigo, segundo as definições explicitadas nestas normas, responsabilizando os autores quanto a existência de plágio e autorizando a Revista Eletrônica de Farmácia sua publicação, devem estar assinados por todos os autores e anexado ao sistema como documento suplementar no momento de submissão do manuscrito.
Os direitos autorais da versão final do artigo são de propriedade da REF. O conteúdo da Revista ficará disponível para toda a comunidade científica.